Received May 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
blew out his eardrum; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of perforated eardrum in a male patient who received Herpes zoster (Shingrix) solution for injection for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced perforated eardrum (Verbatim: blew out his eardrum). The outcome of the perforated eardrum was unknown. It was unknown if the reporter considered the perforated eardrum to be related to Shingrix. Additional Information: GSK Receipt date: 24-MAY-2026 This case was reported by a patient via interactive digital media. The patient was also part of a class-action lawsuit. The patient mentioned don't take shot unless its matter of life and death as they don't tell us that vaccine have risks. The batch number was not provided, and we are unable to contact the reporter.